HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 479 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2023. The put-call ratio across all filers is 2.95 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $290,960 | -64.2% | 2,515 | -68.2% | 0.06% | -57.8% |
| Q2 2023 | $812,412 | +26.2% | 7,899 | +33.9% | 0.14% | +8.9% |
| Q1 2023 | $643,926 | -16.8% | 5,900 | -13.2% | 0.12% | -17.3% |
| Q4 2022 | $773,840 | -86.8% | 6,800 | -92.8% | 0.15% | -87.0% |
| Q3 2022 | $5,846,000 | +47.1% | 94,450 | +89.6% | 1.15% | +43.8% |
| Q2 2022 | $3,974,000 | -23.7% | 49,825 | +0.7% | 0.80% | -13.3% |
| Q1 2022 | $5,205,000 | -1.6% | 49,475 | +0.8% | 0.92% | +16.1% |
| Q4 2021 | $5,288,000 | -71.7% | 49,075 | -71.3% | 0.80% | -48.8% |
| Q3 2021 | $18,701,000 | +17.0% | 170,725 | 0.0% | 1.56% | +20.3% |
| Q2 2021 | $15,987,000 | +21.9% | 170,725 | +19.8% | 1.29% | +30.1% |
| Q1 2021 | $13,113,000 | +1792.2% | 142,475 | +1403.7% | 0.99% | +1928.6% |
| Q4 2020 | $693,000 | -55.9% | 9,475 | -66.5% | 0.05% | -66.0% |
| Q2 2020 | $1,573,000 | – | 28,300 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |